This year has been by far the most pivotal yet for the Foundation, and we want to take a moment to reflect on what our supporters have helped us accomplish, as well as to share a big next step for us in the coming year. Continue reading
The fastest path to better treatment options in the near-term for patients in need is through existing drugs. Our Drug Repurposing Initiative is systematically identifying these treatment options, with the goal of rapidly initiating new, well-justified chordoma clinical trials. Continue reading
Thanks to the generosity of our supporters, significant advances for chordoma patients are being made along multiple paths. Continue reading
Chordoma patients with advanced or metastatic chordoma may soon be eligible to enroll in a new clinical trial testing the FDA-approved cancer drug cetuximab. Continue reading
Our Executive Director, Josh Sommer, hosted a webinar to highlight recent advancements in chordoma research and improvements in the patient experience, as well as the many exciting opportunities now in front of us. Continue reading
If better chordoma treatments are on your holiday wish list, this season of giving is an ideal time to host a virtual fundraiser for the Chordoma Foundation. Continue reading
During the webinar, Jennifer Bires, LCSW, OSW-C, Executive Director of Life with Cancer and Patient Experience at Inova Schar Cancer Institute, and Megan Whetstone, LCSW, an oncology social worker with the Kelsey-Seybold Cancer Center, discussed: common mental health challenges experienced by cancer survivors and co-survivors, ways to manage and cope with these challenges, what type of support is available, and how to get help for yourself or your loved one.
Continue reading
Researchers have identified two molecular subtypes of chordoma associated with different prognoses. They also found that the subtypes can be detected through blood samples, suggesting that someday chordoma diagnosis and prognosis could be determined without biopsy or surgery. Continue reading
During this one-hour webinar, Lisa Ruppert, MD, a physiatrist and cancer rehabilitation expert at Memorial Sloan Kettering Cancer Center, and Justin Brown, MD, a reconstructive neurosurgeon at Massachusetts General Hospital’s Paralysis Center talked about the causes and symptoms of mobility issues in chordoma and how to manage them. Continue reading
Achievements stemming from our recently completed ALL IN campaign have given us much to look forward to, and much to … Continue reading